During the past decade, Northeast Georgia Medical Center conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 135 clinical trials were completed, i.e. on average, 217.7% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 52 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northeast Georgia Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 59 trials, followed by "SCRI Development Innovations, LLC" with 47 trials sponsored, "SWOG Cancer Research Network" with 37 trials sponsored, "Radiation Therapy Oncology Group" with 20 trials sponsored and "Alliance for Clinical Trials in Oncology" with 20 trials sponsored. Other sponsors include 64 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northeast Georgia Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 104 trials as a collaborator, "NRG Oncology" with 39 trials as a collaborator, "Genentech, Inc." with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator and "NCIC Clinical Trials Group" with 9 trials as a collaborator. Other collaborators include 100 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Northeast Georgia Medical Center" are "Breast Cancer" (31 trials), "Lung Cancer" (16 trials), "Prostate Cancer" (12 trials), "Recurrent Ovarian Carcinoma" (12 trials) and "Recurrent Fallopian Tube Carcinoma" (11 trials). Many other conditions were trialed in "Northeast Georgia Medical Center" in a lesser frequency.

Most popular intervention types in "Northeast Georgia Medical Center" are "Drug" (194 trials), "Other" (98 trials), "Biological" (61 trials), "Radiation" (49 trials) and "Procedure" (28 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (58 trials), "Paclitaxel" (37 trials), "Bevacizumab" (33 trials), "Quality-of-Life Assessment" (33 trials) and "Carboplatin" (32 trials). Other intervention names were less common.

The vast majority of trials in "Northeast Georgia Medical Center" are 160 trials for "All" genders, 74 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Northeast Georgia Medical Center". undefined are not yet recruiting, 20 are recruiting, 66 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 143 completed trials in Northeast Georgia Medical Center, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Northeast Georgia Medical Center, 6 "Phase 1" clinical trials were conducted, 106 "Phase 2" clinical trials and 115 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 13 trials that are defined as “Not Applicable".